APRIL 24, 2014
EpiVax CEO/CSO, Dr. Annie De Groot MD, will be one of the featured speakers during next week’s 66th Annual Clinical Laboratory Science Convention. The event is scheduled for April 29 through May 1 at the Rhode Island Convention Center in Providence.
Dr. De Groot will speak on Tuesday, April 29 during a workshop on bioterrorism. Her lecture is titled “Designing Genome-Derived Epitope-Based Vaccines Using Immunoinformatic Tools Against Emerging Pathogens: H7N9 Case Study.” For more information on the event, please click here or visit www.ascls-cne.org/annual-convention to register.
The mission of ASCLS is “to make a positive impact in health care through leadership that will assure excellence in the practice of laboratory medicine.” The membership of ASCLS-CNE is a combination of Massachusetts, Rhode Island and New Hampshire residents. Members “work on behalf of laboratory practitioners and the practice field in an attempt to provide improved diagnostic technologies, patient understanding of testing, access of clinical scientists to quality professional development and legislation promoting professional standards and licensure.”
Interested in learn more about H7N9 vaccine desgin? Check out this recent webinar recording, entitled “Designing an Epitope-Driven Vaccine for a “Stealth Virus” an H7N9 Case Study”.